Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
9.440
+0.140 (+1.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Recursion Pharmaceuticals Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
3 Stocks Under $10 Set to Quadruple by 2025: June Edition
Today 14:40 EDT
Low-priced stocks under $10 can be explosively awarding if you spot the right one at the right time with the right catalyst.
Via
InvestorPlace
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
June 10, 2024
The global
Via
Talk Markets
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
June 07, 2024
The CEO has set a high bar for the business, and if it hits it, the stock could easily 10x in value.
Via
The Motley Fool
Nvidia’s Golden Handshake: 3 Stocks Reaping the Rewards of an NVDA Alliance
June 05, 2024
These Nvidia partner stocks stand to gain from the semiconductor's industry dominance, but they have plenty of upside of their own.
Via
InvestorPlace
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
June 03, 2024
Both of these companies could soon set the standard in their fields.
Via
The Motley Fool
How Is The Market Feeling About Recursion Pharmaceuticals?
May 30, 2024
Via
Benzinga
Recursion Pharm Stock Sees Relative Strength Rating Rise To 84
May 14, 2024
On Tuesday, Recursion Pharm stock had its Relative Strength (RS) Rating upgraded to 84, up from 78 a day earlier.
Via
Investor's Business Daily
Demystifying Recursion Pharmaceuticals: Insights From 4 Analyst Reviews
May 10, 2024
Via
Benzinga
Cathie Wood Owns These 2 AI Stocks. Should You?
June 03, 2024
One looks like a solid option. The other one, not so much.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is Recursion Pharmaceuticals Stock a Millionaire-Maker?
June 02, 2024
Recursion Pharmaceuticals hopes to transform the healthcare industry with the help of AI.
Via
The Motley Fool
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
May 29, 2024
You don't need to buy her picks, but it's worth understanding them.
Via
The Motley Fool
Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week
May 27, 2024
This article highlights the performances last week and MTD of the 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies along with their areas of focus in our...
Via
Talk Markets
2 Stocks That Could 10x by 2035
May 24, 2024
These stocks are very promising, but it's important to consider the downside, too.
Via
The Motley Fool
(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest
May 02, 2024
Via
Benzinga
Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
May 23, 2024
Jim Cramer says Corning has "not been able to generate the kind of return that I've wanted"; calls Recursion a "terrific spec"
Via
Benzinga
A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In
May 20, 2024
The drug development process is very expensive and time-consuming which creates a huge shortage in drug candidates and programs but the advent of AI can significantly shorten and cheapen this process...
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What's the Difference Between Biotech Stocks and TechBio Stocks?
May 15, 2024
A few enterprising businesses are marketing themselves differently.
Via
The Motley Fool
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
May 14, 2024
Via
Benzinga
Recursion Pharmaceuticals Stock Surges 10% As Nvidia-Powered Supercomputer Completion Sparks Investor Optimism
May 13, 2024
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) made waves Monday afternoon not only with the announcement of its groundbreaking BioHive-2 supercomputer but also with a notable surge in its stock...
Via
Benzinga
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
May 13, 2024
Via
Talk Markets
Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 13, 2024
Via
Benzinga
GameStop, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
May 13, 2024
Via
Benzinga
Cathie Wood Is Buying This Under-the-Radar AI Stock
May 12, 2024
This company has massive upside potential, but that's not the whole story.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
RXRX Stock Earnings: Recursion Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
RXRX stock results show that Recursion Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know
May 09, 2024
Recursion reported first-quarter revenue of $13.491 million, which beat analyst estimates of $12.65 million, according to Benzinga Pro. The company reported a quarterly loss of 39 cents per share,...
Via
Benzinga
Nvidia Favorite SoundHound AI Delivers Beat-And-Raise Report
May 09, 2024
SoundHound AI, which counts Nvidia as an investor, beat estimates for the first quarter and with its sales guidance. SOUN stock rose.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
May 05, 2024
We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD.
Via
Talk Markets
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
April 27, 2024
The $50 million purchase could turn into Nvidia's biggest investment.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The Top 3 Biotech Stocks to Buy in April 2024
April 27, 2024
Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances.
Via
InvestorPlace
3 Millionaire-Maker Biotech Stocks
April 25, 2024
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.